Design Therapeutics' Shares Plunge Following Test Results for Treatment of Degenerative Disease

By Adam L. Cataldo Shares of Design Therapeutics dropped in post-market trading after the drug developer said patients in a phase 1 clinical study developed...

Related Keywords

Adam Cataldo ,Adaml Cataldo , ,Design Therapeutics ,Mayo Clinic ,Cleveland Clinic ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Biological Therapy ,Specialized Drugs Medications ,Neurodegenerative Disease Drugs ,Healthcare Provision ,Financial Performance ,Share Price Movement Disruptions ,New Products Services ,Research Development ,Corporate Industrial News ,Products Services ,New Product Service Testing ,Political General News ,Health ,Medical Treatments Procedures ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Dsgn ,Share Price Movement ,Disruptions ,New Products ,Services ,Research ,Development ,Corporate ,Industrial News ,Products ,New Product ,Service Testing ,Political ,General News ,Medical Treatments ,Procedures ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,